CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding CollPlant Biotechnologies Ltd changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 16 | 15 | −1 |
| Shares | 2.45M | 1.96M | −486.3K (−19.9%) |
| Value | $51.9M | $33.1M | −$18.8M (−36.2%) |
New holders (4)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 191,290 | $3.23M | 0.01% |
| Brown Advisory Inc | 61,450 | $1.04M | 0.00% |
| Sigma Planning Corp | 18,635 | $315.0K | 0.01% |
| Renaissance Technologies LLC | 10,001 | $169.0K | 0.00% |
Sold out (5)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Meitav Dash Investments Ltd | 547,730 | $11.6M |
| Friess Associates LLC | 235,092 | $4.99M |
| Raymond James & Associates | 20,800 | $441.0K |
| Citadel Advisors LLC | 13,034 | $276.0K |
| UBS Group AG | 2,010 | $43.0K |